KURA
Kura Oncology, Inc.
Kura Oncology, Inc. (KURA) is currently in an uptrend, trading above both the 50-day and 200-day moving averages. RSI is at 58.5, with 3/3 trend checks passing.
KURA with MA50 and MA200
Key levels & signals
Kura Oncology, Inc. (KURA) is still trading in a constructive trend overall. The latest available price is $11.33, and 3 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 13.0% and above the 200-day moving average by 17.9%.
KURA currently has an RSI reading of 58.5, which leans mildly positive without looking too stretched. In other words, momentum is supportive, but not yet extreme enough to dominate the entire chart read.
For traders reviewing KURA next, the key question is whether the trend still looks healthy or whether price has started to outrun itself. A strong uptrend can stay strong, but entries often become more difficult when price is already extended, so many traders will watch for pullbacks, support reactions, or fresh bases rather than chasing strength blindly.
About Kura Oncology, Inc.
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company’s first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Learn the indicators behind this page
More stock opportunities
Common questions about KURA
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.